Fibromyalgia and stem cell therapy
Fibromyalgia brings widespread pain, exhausting fatigue and poor sleep, and many people spend years seeking a diagnosis, then cycling through medicines that help only partly.
Medically reviewed by:Javier E. Garrido L.MD, MSc
On this page
What is fibromyalgia?
Fibromyalgia is a long-term condition that causes widespread pain in muscles and soft tissues, along with fatigue, unrefreshing sleep and problems with memory and focus, often called fibro fog. Researchers describe it as a disorder of pain processing: the nervous system becomes more sensitive and amplifies pain signals, a process called central sensitization. Blood tests and scans usually look normal, which can make diagnosis slow and frustrating. Fibromyalgia often appears alongside other conditions, such as rheumatoid arthritis, lupus, migraine or irritable bowel syndrome. It affects women more often than men.

At Regeneration Clinic Panama, we take an individualized approach to your care. Our medical team will review your condition, medical history, and individual needs to help you understand your treatment options.
Book a ConsultationCommon signs and symptoms
Because these symptoms overlap with thyroid, rheumatic and other conditions, a thorough medical evaluation comes first.
- Widespread, aching pain on both sides of the body
- Fatigue that sleep does not relieve
- Waking up unrefreshed
- Trouble with memory and focus (fibro fog)
- Tenderness to touch or pressure
- Morning stiffness
- Headaches or migraines
- Low mood or anxiety
- Sensitivity to noise, light or temperature
How fibromyalgia is usually treated
Care for fibromyalgia combines several approaches. Guidelines put gradual, regular exercise, education, sleep care and cognitive behavioral therapy at the center. Three medicines are approved in the US specifically for fibromyalgia: duloxetine, milnacipran and pregabalin, and amitriptyline, an older medicine used at low strength, is also common. Many people benefit from this combination. For many others, medicines bring partial relief or side effects that are hard to tolerate, which is why people with fibromyalgia often keep looking for additional options.

How stem cell therapy works for fibromyalgia
Fibromyalgia is a pain-processing condition, and research has found signs of low-grade inflammation and immune activity in some people who live with it. Mesenchymal stem cells release anti-inflammatory and nerve-supporting factors; in animal models of fibromyalgia, mesenchymal stem cells lowered inflammatory markers and reduced pain-related behaviors. These findings come from laboratory studies, and human trials have yet to be published, so our physicians discuss this openly before any decision. We use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, delivered by IV and, in selected cases, by other routes your physician recommends.
Every patient with fibromyalgia has a different history and set of needs, so we start with a full evaluation. Your physician reviews your history, symptoms, previous treatments and test results before deciding whether a regenerative protocol is appropriate. When it is, cell therapy becomes one part of a personalized care plan.
Important: cellular therapy is an evolving area of medicine. Outcomes vary, and treatment decisions are made individually after a medical assessment.
What the research says
These studies were published by independent research teams. Their results are separate from our own patient outcomes.
- Source link
A study in rats with a laboratory model of fibromyalgia found that bone marrow mesenchymal stem cells improved pain-, fatigue- and mood-related behaviors and lowered inflammatory markers in the brain.
This is animal research and has not been tested in people.
- Source link
A study in 80 rats with a laboratory model of fibromyalgia compared fat-derived (adipose) mesenchymal stem cells with melatonin.
Both reduced muscle damage and behavioral signs of the condition, with stronger effects in the mesenchymal stem cell group; human studies are still needed.
Evidence is very limited: we found no published clinical trial of mesenchymal stem cells in people with fibromyalgia, and current findings come from animal studies only.
Who may consider this
A personalized evaluation may be right for you if you:
- Have a fibromyalgia diagnosis from a rheumatologist or pain specialist
- Have tried exercise programs, sleep care and medicines such as duloxetine or pregabalin
- Have had other causes of widespread pain ruled out
- Want a careful, honest review of what current research can and cannot tell you
- Understand that results vary and no outcome is promised
Our medical team decides suitability after reviewing each case.
What to expect
Before Treatment
Our team reviews your medical history and diagnostic information. We may recommend extra tests to understand your current health and whether you may be a candidate.
During Your Stay
If you are eligible, our medical team guides you through each stage of treatment and provides clinical support throughout.
After Treatment
We follow up at 1, 3, 6, 9 and 12 months after treatment and adjust your plan as needed.

Schedule a personalized consultation to discuss your medical history, treatment goals, and potential care options.
Book a ConsultationRelated articles
Real Patients. Real Results.
Patient stories share individual experiences. Results vary, and no outcome is promised.


- Takes less than 2 minutes
- No commitment
- Takes less than 2 minutes
- No commitment
Your questions
Read Full FAQAnswers about safety, cost and what to expect.
No. Fibromyalgia is a chronic pain condition linked to how the nervous system processes pain. We list it with autoimmune conditions because many people with fibromyalgia also live with rheumatoid arthritis, lupus or similar conditions.
Published research is limited to animal studies so far. Our physicians will walk you through what is known, what is still uncertain and whether mesenchymal stem cell therapy makes sense alongside your current care.
Yes, in most cases. Exercise, sleep care and prescribed medicines remain the foundation of care. Never stop a medicine on your own; our physicians coordinate any changes with your doctors.
Mesenchymal stem cells are recognized for medical use in the European Union and Australia, with hundreds of clinical trials underway worldwide. In December 2024, the FDA approved the first mesenchymal stem cell product in the United States, for steroid-refractory acute graft-versus-host disease in children. For other conditions, mesenchymal stem cell therapy is not FDA-approved in the US.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance. Results vary from patient to patient and no outcome is promised.

Still have a question?
Ask us directly. A patient advocate will reply personally.






